Oligoclonal T cells transiently expand and express TIM3 and LAG3 following CD19 CAR t cell therapy.

被引:0
作者
Petersen, Christopher Thomas
Jagirdar, Neera
Waller, Edmund K.
机构
[1] Emory Univ, Atlanta, GA USA
[2] Emory Clin, Atlanta, GA USA
关键词
D O I
10.1200/JCO.2017.35.15_suppl.e19017
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e19017
引用
收藏
页数:6
相关论文
共 50 条
[31]   A Mouse Model of CD19 CAR - T Cell Therapy Reveals Mechanism of Cytopenia [J].
Grzywacz, Bartosz ;
Tilahun, Ashenafi ;
Wilson, Irena ;
Welk, Kevin ;
Blazar, Bruce R. ;
Pennell, Christopher A. .
BLOOD, 2023, 142
[32]   Remission of acute myeloid leukemia with t(8;21) following CD19 CAR T-cells [J].
Ivetta Danylesko ;
Elad Jacoby ;
Ronit Yerushalmi ;
Noga Shem-Tov ;
Michal J. Besser ;
Helly Vernitsky ;
Victoria Marcu-Malina ;
Avichai Shimoni ;
Abraham Avigdor ;
Arnon Nagler .
Leukemia, 2020, 34 :1939-1942
[33]   Remission of acute myeloid leukemia with t(8;21) following CD19 CAR T-cells [J].
Danylesko, Ivetta ;
Jacoby, Elad ;
Yerushalmi, Ronit ;
Shem-Tov, Noga ;
Besser, Michal J. ;
Vernitsky, Helly ;
Marcu-Malina, Victoria ;
Shimoni, Avichai ;
Avigdor, Abraham ;
Nagler, Arnon .
LEUKEMIA, 2020, 34 (07) :1939-1942
[34]   A targeted TIM3 Knockout by using CRISPR/Cas9 has no direct Effect on the Function of CD19-specific CAR T Cells in vitro, but could still increase CAR T Cell Persistence [J].
Schairer, R. ;
Moraes, Ribeiro E. ;
Korkmaz, F. ;
Lengerke, C. ;
Schneidawind, D. .
ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) :123-123
[35]   T-cells fighting B-cell lymphoproliferative malignancies: the emerging field of CD19 CAR T-cell therapy [J].
Heijink, D. M. ;
Kater, A. P. ;
Hazenberg, M. D. ;
Hagenbeek, A. ;
Kersten, M. J. .
NETHERLANDS JOURNAL OF MEDICINE, 2016, 74 (04) :147-151
[36]   Patterns and Safety of Glucocorticosteroids Use Following CD19 CAR-T Cell Therapy for B- Cell Lymphoma [J].
Luttwak, Efrat ;
Flynn, Jessica R. ;
Devlin, Sean M. ;
Cassanello, Giulio ;
Corona, Magdalena ;
Dahi, Parastoo B. ;
De Abia, Alejandro Luna ;
Fein, Joshua ;
Giralt, Sergio A. ;
Landego, Ivan ;
Lin, Richard J. ;
Palomba, Maria Lia ;
Parascondola, Allison ;
Park, Jae H. ;
Saldia, Amethyst ;
Scordo, Michael ;
Tomas, Ana Alarcon ;
Shah, Gunjan L. ;
Perales, Miguel-Angel ;
Salles, Gilles ;
Shouval, Roni .
BLOOD, 2023, 142
[37]   LAG3 limits the diabetogenicity of intra-islet CD8 T cells [J].
Grebinoski, Stephanie J. ;
Zhang, Qianxia ;
Cillo, Anthony R. ;
Szymczak-Workman, Andrea ;
Workman, Creg ;
Vignali, Dario .
JOURNAL OF IMMUNOLOGY, 2020, 204 (01)
[38]   BCMA CAR T cells in a patient with relapsing idiopathic inflammatory myositis after initial and repeat therapy with CD19 CAR T cells [J].
Mueller, Fabian ;
Wirsching, Andreas ;
Hagen, Melanie ;
Voelkl, Simon ;
Tur, Carlo ;
Raimondo, Maria Gabriella ;
Taubmann, Jule ;
Bucci, Laura ;
Zhang, Liang ;
Kretschmann, Sascha ;
Aigner, Michael ;
Eckstein, Markus ;
Spoerl, Silvia ;
Kharboutli, Soraya ;
Boeltz, Sebastian ;
Atzinger, Armin ;
Munoz, Luis ;
Schett, Georg ;
Mackensen, Andreas ;
Grieshaber-Bouyer, Ricardo .
NATURE MEDICINE, 2025, 31 (06) :1793-1797
[39]   Hemofiltration Successfully Eliminates Severe Cytokine Release Syndrome Following CD19 CAR-T-Cell Therapy [J].
Liu, Yanfen ;
Chen, Xinfeng ;
Wang, Dao ;
Li, Hong ;
Huang, Jianmin ;
Zhang, Zhen ;
Qiao, Yingjin ;
Zhang, Hongling ;
Zeng, Ying ;
Tang, Chao ;
Yang, Shuangning ;
Wan, Xiaochun ;
Chen, Youhai H. ;
Zhang, Yi .
JOURNAL OF IMMUNOTHERAPY, 2018, 41 (09) :406-410
[40]   RAPID GENERATION OF CMV-SPECIFIC CD19 CAR T CELLS: PROTOCOL OPTIMIZATION AND CMV-CD19 CAR T CELL CHARACTERIZATION [J].
Lamb, M. ;
Thakkar, A. ;
Lee, D. A. .
CYTOTHERAPY, 2023, 25 (06) :S235-S235